Literature DB >> 6141080

Epidemiologic observations on the relationship between calcium intake and eclampsia.

J Villar, J M Belizan, P J Fischer.   

Abstract

In Guatemala, the obstetric population has a very low incidence of eclampsia despite the presence of factors that would be expected to favor appearance of the disease. In this study, the eclampsia incidence and calcium intake for three countries, Guatemala (low eclampsia incidence, high calcium intake); Cali, Colombia (high eclampsia incidence, low calcium intake); and the USA (low eclampsia incidence, high calcium intake) have been compared. Crude rates for eclampsia incidence were adjusted to control the effects of well-documented predisposing factors: age, parity, and prenatal care. Results of the study support an association between calcium intake and development of eclampsia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6141080     DOI: 10.1016/0020-7292(83)90016-4

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  11 in total

Review 1.  Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy.

Authors:  J M Moutquin; P R Garner; R F Burrows; E Rey; M E Helewa; I R Lange; S W Rabkin
Journal:  CMAJ       Date:  1997-10-01       Impact factor: 8.262

Review 2.  Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions.

Authors:  Fernando C Barros; Zulfiqar Ahmed Bhutta; Maneesh Batra; Thomas N Hansen; Cesar G Victora; Craig E Rubens
Journal:  BMC Pregnancy Childbirth       Date:  2010-02-23       Impact factor: 3.007

3.  Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy.

Authors:  Esme V Menezes; Mohammad Yawar Yakoob; Tanya Soomro; Rachel A Haws; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

Review 4.  If we know so much about preeclampsia, why haven't we cured the disease?

Authors:  James M Roberts; Mandy J Bell
Journal:  J Reprod Immunol       Date:  2013-07-25       Impact factor: 4.054

5.  Correlation of Vitamin D Levels in Term Normotensive and Pre-eclamptic Patients in Labor.

Authors:  Taru Gupta; Sonika Wahi; Nupur Gupta; Sarika Arora; Sangeeta Gupta; Pushpa Bhatia
Journal:  J Obstet Gynaecol India       Date:  2015-01-22

Review 6.  Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries.

Authors:  Aamer Imdad; Afshan Jabeen; Zulfiqar A Bhutta
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

7.  Randomized, placebo-controlled, calcium supplementation trial in pregnant Gambian women accustomed to a low calcium intake: effects on maternal blood pressure and infant growth.

Authors:  Gail R Goldberg; Landing M A Jarjou; Tim J Cole; Ann Prentice
Journal:  Am J Clin Nutr       Date:  2013-09-04       Impact factor: 7.045

Review 8.  Calcium and Vitamin D Supplementation for Prevention of Preeclampsia: A Systematic Review and Network Meta-Analysis.

Authors:  Win Khaing; Sakda Arj-Ong Vallibhakara; Visasiri Tantrakul; Orawin Vallibhakara; Sasivimol Rattanasiri; Mark McEvoy; John Attia; Ammarin Thakkinstian
Journal:  Nutrients       Date:  2017-10-18       Impact factor: 5.717

9.  Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.

Authors:  G Justus Hofmeyr; Theresa A Lawrie; Álvaro N Atallah; Maria Regina Torloni
Journal:  Cochrane Database Syst Rev       Date:  2018-10-01

10.  The association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in Bangladesh.

Authors:  Fouzia Khanam; Belal Hossain; Sabuj Kanti Mistry; Dipak K Mitra; Wameq Azfar Raza; Mahfuza Rifat; Kaosar Afsana; Mahfuzar Rahman
Journal:  BMC Pregnancy Childbirth       Date:  2018-10-17       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.